Skip to main content
Clinical Trials/NCT04412473
NCT04412473
Unknown
Not Applicable

COVID-19 Respiratory Distress and Antithrombotic Drugs inSubject's Habits

University Hospital, Strasbourg, France1 site in 1 country1,000 target enrollmentApril 30, 2020
ConditionsSars-CoV2

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sars-CoV2
Sponsor
University Hospital, Strasbourg, France
Enrollment
1000
Locations
1
Primary Endpoint
Analysis of Respiratory Distress and Antithrombolytic Therapy in Patients with covid19
Last Updated
5 years ago

Overview

Brief Summary

Current management of VID-19 consists of oxygen support without specific treatment. Hospitalization may suddenly require delayed resuscitation. This evolution corresponds to an atypical acute respiratory distress syndrome (ARDS), the mechanism of which is poorly understood and difficult to predict. The general pathophysiology of ARDS, the vascular tropism of SARS-Cov2, the description of coagulopathy and numerous pulmonary artery thromboses in resuscitation and the encouraging investigation of antithrombotics in general ARDS

Registry
clinicaltrials.gov
Start Date
April 30, 2020
End Date
June 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Major Subject (≥18 years)
  • Subject hospitalised in HUS or GHRMSA for COVID-19
  • The diagnosis COVID-19 confirmed by smear or evoked by CT scan or chest X-ray without a differential diagnosis retained in the medical record
  • Subjects who, after being informed, do not wish to have their data reused for the purposes of this research

Exclusion Criteria

  • Subject who expressed opposition to participating in the study
  • Subject under guardianship or trusteeship
  • Subject under safeguard of justice
  • Patient hospitalized in a geriatric service or in a ward not labeled COVID (surgery, oncology,...) or in a short-term hospitalization unit without transfer to another service.
  • Serious patient on admission to the emergency room and recused from resuscitation.

Outcomes

Primary Outcomes

Analysis of Respiratory Distress and Antithrombolytic Therapy in Patients with covid19

Time Frame: 1 month

Study Sites (1)

Loading locations...

Similar Trials